REAL WORLD DATA ASSESSING THE IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Conferences
Gulati, R; Lee, R; Collins, L; Francis, B; Parish, A; Niedzwiecki, D; Dinani, A
Published in: HEPATOLOGY
October 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 2024
Volume
80
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gulati, R., Lee, R., Collins, L., Francis, B., Parish, A., Niedzwiecki, D., & Dinani, A. (2024). REAL WORLD DATA ASSESSING THE IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE. In HEPATOLOGY (Vol. 80).
Gulati, Reeti, Rachel Lee, Lucas Collins, Berline Francis, Alice Parish, Donna Niedzwiecki, and Amreen Dinani. “REAL WORLD DATA ASSESSING THE IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE.” In HEPATOLOGY, Vol. 80, 2024.
Gulati R, Lee R, Collins L, Francis B, Parish A, Niedzwiecki D, et al. REAL WORLD DATA ASSESSING THE IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE. In: HEPATOLOGY. 2024.
Gulati, Reeti, et al. “REAL WORLD DATA ASSESSING THE IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE.” HEPATOLOGY, vol. 80, 2024.
Gulati R, Lee R, Collins L, Francis B, Parish A, Niedzwiecki D, Dinani A. REAL WORLD DATA ASSESSING THE IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE. HEPATOLOGY. 2024.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 2024
Volume
80
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences